UPDATE: RBC Capital Upgrades Amneal Pharmaceuticals (AMRX) to Outperform; EBITDA Ramp is Beginning
Tweet Send to a Friend
(Updated - August 13, 2018 7:12 AM EDT)
(updated to add analyst comments)RBC Capital analyst Randall Stanicky upgraded Amneal ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
(updated to add analyst comments)RBC Capital analyst Randall Stanicky upgraded Amneal ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
